Kostensensible Leitlinien : Evidenzbasierte Leistungssteuerung für eine effiziente und gerechte Gesundheitsversorgung

"Medical innovations and demographic change will further exacerbate the financial situation in the German healthcare system in the coming years. The evidence-based allocation of the limited funds available will therefore become increasingly important. From an ethical perspective, allocation dec...

Full description

Bibliographic Details
Other Authors: Marckmann, Georg (Editor)
Format: eBook
Published: Berlin MWV Medizinisch Wissenschaftliche Verlagsgesellschaft 2015
Subjects:
MBN
Online Access:Get fulltext
LEADER 02175naaaa2200301uu 4500
001 39724
005 20200618
020 |a 9783954664580-2 
024 7 |a 10.32745/9783954664580-2  |c doi 
041 0 |h German 
042 |a dc 
100 1 |a Marckmann, Georg  |e edt 
856 |z Get fulltext  |u http://library.oapen.org/handle/20.500.12657/39724 
700 1 |a Marckmann, Georg  |e oth 
245 1 0 |a Kostensensible Leitlinien : Evidenzbasierte Leistungssteuerung für eine effiziente und gerechte Gesundheitsversorgung 
260 |a Berlin  |b MWV Medizinisch Wissenschaftliche Verlagsgesellschaft  |c 2015 
300 |a 1 electronic resource (209 p.) 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a "Medical innovations and demographic change will further exacerbate the financial situation in the German healthcare system in the coming years. The evidence-based allocation of the limited funds available will therefore become increasingly important. From an ethical perspective, allocation decisions should be based on clearly defined procedures and criteria. So far, however, there are no concrete approaches on how this explicit performance control can be implemented in practice. The book provides an overview of the results of the interdisciplinary research association ""Allocation"", which for the first time examined the possibilities and limits of explicit performance management in two selected practical areas (interventional cardiology and intensive care medicine). Two exemplary cost-sensitive guidelines have been developed that enable an evidence-based balance between efficiency and justice. The legal requirements for such an explicit benefit management in statutory health insurance were examined in detail. Healthcare professionals and patients were asked for their assessments of the strengths and weaknesses of the cost-sensitive guidelines." 
540 |a Creative Commons 
546 |a German 
650 7 |a MBN  |2 bicssc 
650 7 |a Public health & preventive medicine  |2 bicssc 
653 |a cost sensitivity 
653 |a assessment of benefit 
653 |a scarcity of capital 
653 |a evidence based medicine 
653 |a prioritization